Publikationen in Zusammenarbeit mit Forschern von Hospital Infantil Universitario Niño Jesus de Madrid (210)

2024

  1. Role of the mesenchymal stromal cells in bone marrow failure of Fanconi Anemia patients

    Frontiers in Cell and Developmental Biology, Vol. 12

2023

  1. Adverse events related to central venous catheters (CVC) and the influence of CVC characteristics on peripheral blood hematopoietic progenitor cell collection in children

    Frontiers in Pediatrics, Vol. 11

2022

  1. Extracorporeal photopheresis in paediatric patients: A retrospective comparison between different ‘off-line’ protocols

    Vox Sanguinis, Vol. 117, Núm. 10, pp. 1220-1229

  2. Mobilization with high-dose granulocyte colony-stimulating factor alone at 12 μg/kg twice a day in high-risk pediatric patients: A retrospective analysis of the experience in a single center

    Journal of Clinical Apheresis, Vol. 37, Núm. 5, pp. 420-429

  3. Neuroblastoma in Spain: Linking the national clinical database and epidemiological registries – A study by the Joint Action on Rare Cancers

    Cancer Epidemiology, Vol. 78

  4. Validity and Reliability of a Nutritional Screening Tool (SCAN) in Children Newly Diagnosed with Cancer

    Nutrition and Cancer, Vol. 74, Núm. 5, pp. 1754-1765

2021

  1. Next-generation Sequencing in Bone Marrow Failure Syndromes and Isolated Cytopenias: Experience of the Spanish Network on Bone Marrow Failure Syndromes

    HemaSphere, Vol. 5, Núm. 4

  2. Plerixafor-based mobilization in pediatric healthy donors with unfavorable donor/recipient body weight ratio resulted in a better CD34+ collection yield: A retrospective analysis

    Journal of Clinical Apheresis, Vol. 36, Núm. 1, pp. 78-86

2020

  1. COVID-19 infection in children and adolescents with cancer in Madrid

    Pediatric Blood and Cancer

  2. Can monitoring asparaginase activity help us to manage toxicity in pediatric acute lymphoblastic leukemia?

    Leukemia and Lymphoma

  3. Comment on: “Early advice on managing children with cancer during the COVID-19 pandemic and a call for sharing experiences”

    Pediatric Blood and Cancer

  4. First-in-Human, First-in-Child Trial of Autologous MSCs Carrying the Oncolytic Virus Icovir-5 in Patients with Advanced Tumors

    Molecular Therapy, Vol. 28, Núm. 4, pp. 1033-1042

  5. Gemcitabine, paclitaxel, and oxaliplatin (GEMPOX) in the treatment of relapsed/refractory intracranial nongerminomatous germ cell tumors

    Pediatric Blood and Cancer, Vol. 67, Núm. 2

  6. Genetic and immune changes associated with disease progression under the pressure of oncolytic therapy in a neuroblastoma outlier patient

    Cancers, Vol. 12, Núm. 5

  7. Inhospital exercise benefits in childhood cancer: A prospective cohort study

    Scandinavian Journal of Medicine and Science in Sports, Vol. 30, Núm. 1, pp. 126-134

  8. Initial report on Spanish pediatric oncologic, hematologic, and post stem cell transplantation patients during SARS-CoV-2 pandemic

    Pediatric Blood and Cancer

  9. Treatment of radiation-induced myelopathy with bevacizumab

    Clinical and Translational Oncology

2019

  1. Improving the quality of care in the molecular era for children and adolescents with medulloblastoma

    Clinical and Translational Oncology, Vol. 21, Núm. 12, pp. 1687-1698

  2. Old drugs still work! Oral etoposide in a relapsed medulloblastoma

    Child's Nervous System, Vol. 35, Núm. 5, pp. 865-869

2018

  1. Glioblastoma, 47XXY/45,X mosaicism, and hyperpigmented skin lesions

    Pediatric Blood and Cancer